State vs. Central Licensing: Which One Applies to Your Blood Center?

In the pharmaceutical industry, the blood centers play a crucial role. Blood centers are responsible for managing the blood and blood components. Since CDSCO declared blood and blood products life-saving drugs and therapies, securing the license for them has become essential. The certified blood banks supply the plasma for multiple uses, like producing clotting factors, albumin, and other therapeutic products. But, how the supply components quality are verified? This is where the drug store license is used. It determines that the blood banks are required to meet the relevant regulations. 

Have you ever wondered how the state and central licensing authorities are involved in providing the drug or medical certificate in India? In this comprehensive guide, we will discover the role of the state vs. the central licensing authority in providing a blood center drug license, its importance, the process, and much more. Let’s explore it more. 

Role of the State Licensing Authority for Blood Centers

Within the state, the State Licensing Authority (SLA) oversees the operations to ensure the safety and quality of blood and blood components. The SLA further operates the activities of licensing, inspection, and enforcement. The regulation by state authority determines the blood collection, processing, storage, and many other aspects. The major aim is to mandate the drug safety certification to prevent transfusion-transmissible infections. All operations are managed by ensuring the availability of safe food for the consumers. Here is a more detailed breakdown of the State Licensing Authority (SLA):

• As per the guidelines of SLA, whoever is associated with blood and blood component operations needs to obtain the drug certificate. Through the drug license registration, the blood centers can operate legally within the state.
• During the registration, the authority reviews the application form, conducts a premises inspection, and ensures compliance with standards.
• The State Licensing Authority regulates the license renewal and also ensures that the blood center’s operations change. SLA is governed under the Drugs and Cosmetics Act and other relevant laws. It is crucial to ensure that blood centers comply with safety and quality standards. 
• In a non-compliance case, the authority takes strict action and also warns by imposing fines or suspending the valid certificate. To make all regulations with the operation seamless, the State Licensing Authority (SLA) works closely with the national regulatory authority, Central Drugs Standard Control Organization (CDSCO). 
• Imposes the policies and guidelines related to blood transfusion services by collaborating with State Blood Transfusion Councils (SBTCs). 

Role of the Central Licensing Authority for Blood Center

The head of CDSCO, the Drugs Controller General (India) (DCGI), is responsible for regulating the blood banks. DCGI, the Central Licensing Authority, issues the license, including renewals and cancellations, for blood centers. By regulating all activities of blood centers, the authority gets access to blood and blood products’ safety, quality, and ethical practices. The key responsibilities of the Central Licensing Authority are

• In the healthcare industry, DCGI serves as the Central Licensing Authority. It is the initial body for issuing the license to blood bank operators. The authority further ensures that they meet the specified necessary criteria for all drug operations.
• The authority enforces the regulations under the Drugs and Cosmetics Act and Rules. To meet these rules and regulations, blood banks are required to manage quality controls and maintain records.
• The Central Licensing Authority collaborates with the State Licensing Authority to provide national-level oversight of blood transfusion services.
• DCGI sets the national standard for blood transfusion services by collaborating with the National Blood Transfusion Council (NBTC). 
• Like SLA, the Central Licensing Authority also conducts premises inspections to ensure blood center compliance with regulations. 

State Licensing Authority vs. Central Licensing Authority

Both the state licensing authority and the central licensing authority are involved in regulating the blood center operations in India. Meanwhile, SLA is responsible for issuing the initial license, whereas CLA oversees and approves the issuance of the drug license registration. Both are engaged for a common purpose, which is blood safety and quality. In India, the initial licensing authority is the State Drugs Controller, which works within a specific state. Furthermore, the blood banks that want to obtain the drug license apply online first through the State Licensing Authority. Here is the dual licensing process

Application: For the blood and blood component storage, collection, or distribution, the blood banks register the application through the State Licensing Authority.

Final Approval: The State DC gets the application form for blood banks, which is further forwarded to the DCGI for final approval. 

Compliance: DCGI approves the drug license. By collaborating, both ensure that blood centers must adhere to state and central regulations. 

 Final Discussion |  Pharmacy License Apply Online

In essence, the drug licensing is crucial to oversee the blood collection, storage, and other activities. By overseeing the operations, it promotes the safe service to the patients. Furthermore, the state DC works to issue the initial drug certificate. But the approval of DCGI for the drug safety certification is further important for blood banks to legally operate. Before issuing the license, the authority ensures adherence to national standards for safety and quality of blood. To obtain the drug certificate for your blood center, comply with the state as well as the central licensing authority.